Mar/Apr 2020 - Volume 24, Number 2

Purchase or view individual articles by selecting the article in the table below...

Individual Articles - Mar/Apr 2020 - Volume 24, Number 2

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2020 Pg. 92	PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 94-96	Low-dose Naltrexone Therapy for Psoriasis Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Mar/Apr 2020 Pg. 98-102	Compounding Pearls -- Wound Care: Base Selection Author(s): Riepl Mike
Mar/Apr 2020 Pg. 104-108	Low-dose Pilocarpine Spray to Treat Xerostomia Author(s): Zur Eyal
Mar/Apr 2020 Pg. 110-113	A "North Star" for Pharmacy Compounders Author(s): Brunner Scott
Mar/Apr 2020 Pg. 114-118	Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 121-126	Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 128	Calculations Author(s): Stockton Shelly J
Mar/Apr 2020 Pg. 130	Acetazolamide 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 131	Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 132	Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 133	Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 134	Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 135	Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 136	Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 137	Terbinafine 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 138	Topiramate 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 139	Valsartan 4 mg/mL in Syrup NF Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 140-147	The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Author(s): Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2020 Pg. 148-155	Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets Author(s): Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
Mar/Apr 2020 Pg. 156-162	Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia Author(s): Sorrieul Jérémy, Robert Julien, Chapel Fanny, Gossye Thomas, Devys Catherine
Mar/Apr 2020 Pg. 163-167	Feasibility Study of Asthma Cream Author(s): Kuang Andrew
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard